{'fraction_non_alphanumeric': 0.019011406844106463, 'fraction_numerical': 0.0, 'mean_word_length': 5.120930232558139, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Experience with the drug Akatinol memantine in the treatment of early stage dementia of the Alzheimer type

The increase in number of older people makes the study of their health very (actual) topical. The problem of dementia in the first place ‐ dementia, Alzheimer's type, has been steadily growing. This is explained by the frequency of Alzheimer's disease (AD), long debilitating disease course and large economic costs of treatment and care for patients who require lifelong institutionalization for chronically mentally ill. In Armenia, there is still no reliable data on the prevalence of asthma. Low uptake of these patients for psychiatric care leads to low detectability of their psychopathology. Older persons may form a wide range of cognitive impairment ‐ from mild weakening of attention and psychomotor retardation, which are associated with the consequent aging of the nervous tissue and may be regarded as age norm, to the most severe form of cognitive impairment, which is expressed in the development of dementia. In recent years, increasing attention has attracted to an intermediate stage in the development of cognitive impairment when they have not yet reached the degree of dementia, but out of the boundaries of age norms. And it requires special attention and possible preventive measures.